Multi-condition Pathway Intervention for Bronchiolitis

Phase-Based Progress Estimates
Bronchiolitis+2 MoreMulti-condition Pathway Intervention - Behavioral
< 18
All Sexes
What conditions do you have?

Study Summary

This trial will test whether a multi-condition clinical pathway intervention can help community hospitals improve care for children with asthma, pneumonia, or bronchiolitis.

Eligible Conditions
  • Bronchiolitis
  • Pneumonia
  • Asthma

Treatment Effectiveness

Study Objectives

7 Primary · 3 Secondary · Reporting Duration: 30 days after hospital discharge

Day 30
30-day Hospital Readmission or Emergency Department Revisit
Day 2
Asthma Evidence Based Practice 1
Asthma Evidence Based Practice 2
Asthma Evidence Based Practice 3
Bronchiolitis Evidence Based Practice 1
Bronchiolitis Evidence Based Practice 2
Length of Hospital Stay
Pneumonia Evidence Based Practice 1
Pneumonia Evidence Based Practice 2
Transfer to Intensive Care

Trial Safety

Trial Design

2 Treatment Groups

Standard of Care
1 of 2
Multi-condition Pathway Intervention
1 of 2

Active Control

Experimental Treatment

16800 Total Participants · 2 Treatment Groups

Primary Treatment: Multi-condition Pathway Intervention · No Placebo Group · N/A

Multi-condition Pathway Intervention
Experimental Group · 1 Intervention: Multi-condition Pathway Intervention · Intervention Types: Behavioral
Standard of CareNoIntervention Group · 1 Intervention: Standard of Care · Intervention Types:

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 30 days after hospital discharge

Who is running the clinical trial?

National Heart, Lung, and Blood Institute (NHLBI)NIH
3,588 Previous Clinical Trials
46,929,199 Total Patients Enrolled
6 Trials studying Bronchiolitis
8,006 Patients Enrolled for Bronchiolitis
University of California, San FranciscoLead Sponsor
2,279 Previous Clinical Trials
11,560,488 Total Patients Enrolled
Society of Hospital MedicineOTHER
4 Previous Clinical Trials
7,154 Total Patients Enrolled
Sunitha V Kaiser, MD, MScPrincipal InvestigatorUniversity of California, San Francisco

Eligibility Criteria

Age < 18 · All Participants · 1 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you: